Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors

B. Bjornhart; M. Mouritzen; C. Kristiansen; K. H. Holmskov; K. Wedervang; T. L. Jorgensen; J. Herrstedt; M. Pohl; T. Schytte

doi:10.1016/j.annonc.2022.07.1239

Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors

B. Bjornhart, M. Mouritzen, C. Kristiansen, K. H. Holmskov, K. Wedervang, T. L. Jorgensen, J. Herrstedt, M. Pohl, T. Schytte

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	1114P
Tidsskrift	Annals of Oncology
Vol/bind	33
Udgave nummer	Suppl. 7
Sider (fra-til)	S1060
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2022.07.1239
Status	Udgivet - sep. 2022
Begivenhed	ESMO Congress 2022 - Paris Expo Porte de Versailles, Paris, Frankrig Varighed: 9 sep. 2022 → 13 sep. 2022 https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022

Konference

Konference	ESMO Congress 2022
Lokation	Paris Expo Porte de Versailles
Land/Område	Frankrig
By	Paris
Periode	09/09/2022 → 13/09/2022
Internetadresse	https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022

Bibliografisk note

Abstrakt No. 1114P

Adgang til dokumentet

10.1016/j.annonc.2022.07.1239

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Bjornhart, B., Mouritzen, M., Kristiansen, C., Holmskov, K. H., Wedervang, K., Jorgensen, T. L., Herrstedt, J., Pohl, M., & Schytte, T. (2022). Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors. Annals of Oncology, 33(Suppl. 7), S1060. Artikel 1114P. https://doi.org/10.1016/j.annonc.2022.07.1239

@article{b90fc9e05c4547309d6349ba01c7d8c2,

title = "Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors",

author = "B. Bjornhart and M. Mouritzen and C. Kristiansen and Holmskov, {K. H.} and K. Wedervang and Jorgensen, {T. L.} and J. Herrstedt and M. Pohl and T. Schytte",

note = "Abstract No. 1114P; ESMO Congress 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.1239",

language = "English",

volume = "33",

pages = "S1060",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 7",

url = "https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022",

}

Bjornhart, B, Mouritzen, M, Kristiansen, C, Holmskov, KH, Wedervang, K, Jorgensen, TL, Herrstedt, J, Pohl, M & Schytte, T 2022, 'Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors', Annals of Oncology, bind 33, nr. Suppl. 7, 1114P, s. S1060. https://doi.org/10.1016/j.annonc.2022.07.1239

TY - ABST

T1 - Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors

AU - Bjornhart, B.

AU - Mouritzen, M.

AU - Kristiansen, C.

AU - Holmskov, K. H.

AU - Wedervang, K.

AU - Jorgensen, T. L.

AU - Herrstedt, J.

AU - Pohl, M.

AU - Schytte, T.

N1 - Abstract No. 1114P

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.annonc.2022.07.1239

DO - 10.1016/j.annonc.2022.07.1239

M3 - Conference abstract in journal

SN - 0923-7534

VL - 33

SP - S1060

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 7

M1 - 1114P

T2 - ESMO Congress 2022

Y2 - 9 September 2022 through 13 September 2022

ER -